| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8223231 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 8 Pages |
Abstract
In anal cancer, even in the case of initial perirectal node invasion, BCT boost is superior to EBRT boost for CRLR, without an influence on OS, suggesting that N1 status should not be a contraindication to use of a BCT boost technique, as well as emphasizing the important of investigating the benefit of BCT boost in prospective randomized trials.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Laurence MD, Cecile MD, PhD, Jean-Michel MD, PhD, Eric MD, Didier MD, PhD, Nagi MD, Claire MD, Steve MD, Michel MD,